Domo (DOMO) Q3 2026 earnings review
Profitability Achieved, But Growth Stalls Amid Leadership Shock
Domo's Q3 results present a stark contrast between improving financial discipline and top-line stagnation. The company achieved its third consecutive quarter of positive adjusted Free Cash Flow ($2.1M) and a solid 7% Non-GAAP operating margin. However, revenue remains stubbornly flat year-over-year at $79.4M, and billings missed guidance ($73.2M actual vs. expected) due to lengthening sales cycles. The transition to an 80% consumption-based ARR model is showing promise, yet the abrupt announcement of CEO Josh James entering a residential treatment program for alcohol abuse introduces significant leadership uncertainty right when the company needs to execute a crucial Q4 rebound.
🐂 Bull Case
The company has achieved three consecutive quarters of positive adjusted free cash flow and is on track to deliver its first-ever full year of positive FCF (~$6M) alongside a record 5% annual operating margin.
80% of ARR is now on a consumption-based model (up from single digits two years ago). This cohort boasts a 106% Net Revenue Retention (NRR) rate, signaling strong future upsell potential as usage scales.
🐻 Bear Case
The CEO's medical leave for substance abuse treatment creates a leadership vacuum and operational distraction during the critical Q4 closing period.
Q3 billings missed guidance as strategic, partner-led deals stalled. Management's reliance on a massive Q4 rebound (+6% YoY billings growth) carries high execution risk in a tight macro environment.
⚖️ Verdict: ⚪
Neutral. The structural improvements to margins and cash flow are impressive and limit downside risk. However, top-line growth has flatlined, and betting on a Q4 billings acceleration while the CEO enters rehab requires too much faith.
Key Themes
Leadership Uncertainty at a Critical Juncture
CEO Josh James announced he is entering a residential treatment center for alcohol abuse. While he stated he will continue his duties, running a public company mid-turnaround from a rehab facility is highly unorthodox. This introduces severe execution risk, potential distraction for the executive team, and leverage for competitors during Q4 sales negotiations.
Billings Miss Driven by Elongated Sales Cycles
Q3 Billings came in at $73.2M, missing guidance. Management blamed longer-than-expected sales cycles on their new partner-led deals, which require higher-level (CIO) approvals. This macro-driven scrutiny on IT budgets means the timeline from pipeline generation to actual cash is decelerating, forcing Domo to push revenue expectations into Q4.
Contradiction: Overall Net Retention Remains Broken
Management heavily touts the 106% NRR of their consumption cohort. However, the total company ARR Net Retention sits at 95%. While this is a stable sequential improvement, it remains fundamentally below the 100% breakeven mark. This specific data point contradicts the narrative of a fully successful turnaround—the legacy customer base is still churning faster than the new model can replace it.
Partner Ecosystem Pipeline is Accelerating
The go-to-market pivot to integrate with Cloud Data Warehouses (CDWs) like Snowflake and Databricks is working at the top of the funnel. Partner-sourced leads increased by over 25% sequentially vs Q2. If Domo can solve the sales cycle elongation (Concern #2), this partner channel represents a durable, lower-CAC growth engine.
Consumption Model Unlocks Adoption
Domo has successfully flipped its revenue base: 80% of ARR is now consumption-based. By removing seat-based licensing friction, monthly active users are up >10% YoY. This land-and-expand approach directly aligns Domo's revenue with customer usage, effectively stabilizing the platform's long-term stickiness.
Agentic AI Driving User Engagement
Domo is successfully catching the AI tailwind. The number of unique accounts utilizing its AI features grew over 60% YoY, and unique users more than doubled. Product innovations in AI workflows are transitioning Domo from a passive dashboard tool to an active operational platform, validated by a #1 ranking in Dresner's 2025 AgenTeq AI report.
Other KPIs
Reversing the historical cash burn. This represents a 115% YoY increase and marks the third consecutive quarter of positive adjusted FCF. Domo has fundamentally restructured its cost base to self-fund operations, a critical survival metric for small-cap software in the current rate environment.
Accelerating long-term commitments. Total Subscription RPO grew 15% YoY, significantly outpacing flat revenue growth. This divergence indicates that while current revenue recognition is stalled, customers are signing longer-term contracts (multi-year deals), locking in future revenue.
Accelerating profitability. Improved 4 percentage points YoY. Management is executing tightly on expenses, allowing them to extract margin even when top-line revenue misses expectations.
Guidance
Accelerating. The midpoint ($108.5M) implies 6% YoY growth, which would be the fastest growth rate in over three years. This requires a massive execution quarter to close the deals that slipped out of Q3.
Decelerating. Revenue is guided down sequentially from Q3's $79.4M and down YoY from Q4 FY25's $78.8M. The delay in Q3 billings translates directly to delayed revenue recognition in Q4.
Reversing. Moving from a cash burn in FY25 to the company's first-ever full year of positive adjusted free cash flow. This metric confirms the business model transformation has permanently fixed the cash drain.
Key Questions
Leadership Structure During Treatment
With Josh James entering residential treatment during the crucial Q4 closing period, how are day-to-day operations and key CIO-level partner negotiations being delegated to ensure deals do not slip further?
Confidence in Q4 Billings Rebound
Guidance calls for the fastest billings growth in three years (+6% YoY) in Q4. What quantitative pipeline metrics give you the confidence that Q3's miss was purely a timing issue and not a competitive loss?
Timeline to Positive Net Retention
Total company NRR sits at 95%. Given the 106% NRR of the consumption cohort (now 80% of ARR), in what specific quarter do you project total company NRR will finally cross the 100% breakeven threshold?